147239-40-5

Upstream product

• 135363-93-8 [1-((2R,3R,4S)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-allyloxy]-tert-butyl-dimethyl-silane 
• 135363-92-7 1-((2R,3R,4S)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-prop-2-en-1-ol 
• 135363-91-6 (2R,3R,4S)-3,4-Bis-benzyloxymethyl-oxetane-2-carbaldehyde 

Downstream Products

• 135363-94-9 ((2R,3R,4S)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-(tert-butyl-dimethyl-silanyloxy)-acetic acid methyl ester 
• 135363-98-3 3-((2R,3S,4S)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-pyrrole-2,5-dione 
• 135363-96-1 ((2R,3R,4S)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-oxo-acetic acid methyl ester 
• 135363-95-0 ((2R,3R,4S)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-hydroxy-acetic acid methyl ester 
• 135363-97-2 trans-3,4-bis(benzyloxymethyl)oxetan-2-one 
• 147239-41-6 ((2R,3R,4S)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-(tert-butyl-dimethyl-silanyloxy)-acetaldehyde 

Relevant academic research and scientific papers

Synthetic studies on oxetanocin analogs: Synthesis of oxetanosyl c-nucleoside, 2-deoxy-2-hydroxymethyl-β-D-erythrooxetanosyl maleimide

Synthesis of oxetanosyl C-nucleoside similar to showdomycin, 2-deoxy-2-hydroxy-methyl-β-D-erythrooxetanosyl maleimide has successfully been carried out starting from the potent intermediate of oxetanocin synthesis.